Supporting 5,200 patient eligibility determinations across 900 Oncology trials in every phase

Jun 5, 2024

3

 min read

The escalating prevalence of cardiometabolic diseases significantly underscores their importance in the realm of global clinical trials.

Jun 5, 2024

3

 min read

From Pediatric Sickle Cell to Mitochondrial Disease, Rare Disease research is powered by Judi

Jun 5, 2024

3

 min read

Judi is transforming global clinical development across 20 therapeutic areas and countless indications.

Jun 5, 2024

3

 min read

Prominent clinical-stage biotech combines Judi for Eligibility and Judi for Adjudication

Feb 20, 2024

5

 min read

Prominent clinical-stage biotech combines Judi for Eligibility and Judi for Adjudication on pivotal Phase 2 CAR-T oncology trial with over 600 endpoints

International biopharma sponsor and partner CRO maximize flexibility of Judi for DSMB for Phase 2 multinational clinical program with over 100 patients and 60 sites

US-based biopharma leverages scalability of Judi for Imaging on three concurrent pulmonary oncology trials

United States-based medical device sponsor and partner CRO leverage flexibility of Judi for DSMB for novel cardiovascular implant trial with over 100 patients and 25 sites

Large Language Models and Neural Networks for Redaction, Endpoint Adjudication and Central Eligibility Reviews